Overview of Emeprid
| Property | Description |
|---|---|
| Active ingredient | Metoclopramide hydrochloride (INN) |
| Forms | Tablets, oral solution, solution for injection |
| Pharmacological class | Antiemetic and Prokinetic Agent |
| General purpose | Addresses nausea, vomiting, and reduced gut motility |
| Origin | Synthetic (Benzamide derivative) |
Emeprid: Core Identity and Pharmacological Classification
Emeprid is a brand-name pharmaceutical preparation containing the synthetic compound Metoclopramide hydrochloride (INN), a substance belonging chemically to the benzamide derivative family. This medicine is defined by its dual pharmacological class: it operates both as an antiemetic (sickness reliever) and a prokinetic agent (gastrointestinal stimulant). This classification defines the medicine's role in the management of digestive symptoms.
This dual functionality is important because the drug offers a comprehensive approach. Unlike medicines that only suppress the sensation of sickness, Metoclopramide provides the distinct added function of physically improving the movement and coordination of the stomach and intestines. This makes the drug a core entity in managing discomfort where both sickness and sluggish digestive movement, or reduced gastro-intestinal motility, are present.
Composition, Forms, and General Purpose
The medication is a single-ingredient product, containing only Metoclopramide as its primary therapeutic substance, combined with either an aqueous solution or solid excipients. The drug is manufactured into various dosage forms, including tablets, oral solution, and solution for injection, allowing for both oral and parenteral routes of administration. The Emeprid brand is often positioned for veterinary use, highlighting a specific target audience, though its active ingredient is widely utilized across human and animal medicine.
The high-level general therapeutic purpose is to address the discomfort and symptoms related to nausea and vomiting by restoring normal function to the upper digestive tract. Metoclopramide stimulates the upper gastrointestinal tract and reduces symptoms of nausea, helping the body restore a smoother digestive rhythm.
Mechanism Principles (Basic Action)
The medicine achieves its effect by employing a dual action: it works centrally to block signals that trigger sickness in the brain, and it works peripherally to increase the tone and coordination of the digestive tract. This dual functionality allows it to target the perception of sickness while also promoting a smoother, more coordinated progression of contents from the stomach. This core action of improving stomach emptying is vital for its utility as a gastrointestinal stimulant.
